Diffusion of new technologies is dependent on healthcare policy, and the diversity and complexity of policies can pose a challenge to medtech manufacturers, making healthcare policy research and monitoring critical to the success of your technology.
Reimbursement is one of the most important policies impacting medtech manufacturers.
Reimbursement is not a “one-size fits-all” process, and keeping up with evolving policies and legislation surrounding reimbursement is critical.
DID YOU KNOW?
Technologies with clinical applications that meet policy “calls to action” have significant opportunity for accelerated market adoption with evidence of value.
Public policy is entangled in decisions at essentially every stage of the product development lifecycle.
Public policy directly impacts the funding of research endeavors, affecting the speed at which medical advancements are introduced.
HOW WE CAN HELP
By monitoring policy and legislation at national and local levels, our experts are able to provide you with up to date information on reforms and pivot your reimbursement strategy accordingly to ensure the highest level of reimbursement for your technology.
We can prepare a summary report of key payer policies for coverage and payment regarding treatment of indicated conditions.
Also notable, we have significant experience conducting studies that have impacted policy.